Reply

The changes of BCVA were 0.10 ± 0.37 in polypoidal CNV and 0.13 ± 0.18 in idiopathic PCV, with no significant difference between the 2 groups (P = .740). [...]in our study, there were no significant differences between polypoidal CNV and idiopathic PCV in both anti-vascular endothelial growth factor...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of ophthalmology 2017-02, Vol.174, p.182
Hauptverfasser: Maruyama-Inoue, Maiko, Yamane, Shin, Sato, Shimpei, Kadonosono, Kazuaki
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The changes of BCVA were 0.10 ± 0.37 in polypoidal CNV and 0.13 ± 0.18 in idiopathic PCV, with no significant difference between the 2 groups (P = .740). [...]in our study, there were no significant differences between polypoidal CNV and idiopathic PCV in both anti-vascular endothelial growth factor (VEGF) agents during the 1-year follow-up period. Because fellow eyes covered diseased eyes, some patients could not notice their symptoms and did not know exactly the onset of AMD.
ISSN:0002-9394
1879-1891
DOI:10.1016/j.ajo.2016.11.008